Unknown

Dataset Information

0

Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors.


ABSTRACT: BACKGROUND:Neuropeptide Y (NPY) has been implicated in a wide variety of physiological processes, including feeding, learning, memory, emotion, cardiovascular homeostasis, hormone secretion, and circadian rhythms. NPY Yl receptor (NPY Y1-R) is the most widely studied NPY receptor, and is involved in many of these processes. BMS-193885 (1) was previously developed as a potent and selective NPY Y1-R antagonist, which has good systemic bioavailability and brain penetration. To evaluate the characteristics of 1 in vivo, we developed 11C-labeled BMS-193885 ([11C]1) and its desmethyl analog ([11C]2) for potential use as two new positron emission tomography (PET) tracers. RESULTS:[11C]1 was synthesized from [11C]methyl iodide using 2. [11C]2 was synthesized from [11C]phosgene using its aniline and amine derivatives. The mean?±?S.D. decay-corrected radiochemical yields of [11C]1 and [11C]2 from 11CO2 at the end of radionuclide production were 23?±?3.2% (n?=?6) and 24?±?1.5% (n?=?4), respectively. In biodistribution on mice, radioactivity levels for both tracers were relatively high in the kidney, small intestine, and liver at 60?min post-injection. The radioactivity levels in the kidney, lung, and spleen of mice at 30?min post-injection with [11C]1 were significantly reduced by pretreatment with 1 (10?mg/kg), and levels of [11C]1 in the brain of mice were significantly increased by pretreatment with the P-glycoprotein and breast cancer resistance protein inhibitor elacridar (10?mg/kg). In metabolite analysis using mouse plasma, [11C]1 and [11C]2 were rapidly metabolized within 30?min post-injection, and [11C]1 was mainly metabolized into unlabeled 2 and radiolabeled components. CONCLUSION:[11C]1 and [11C]2 were successfully synthesized with sufficient amount of radioactivity and high quality for use in vivo. Our study of [11C]1 and its desmethyl analog [11C]2 was useful in that it helped to elucidate the in vivo characteristics of 1.

SUBMITTER: Kawamura K 

PROVIDER: S-EPMC6379498 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Radiosynthesis and in vivo evaluation of <sup>11</sup>C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors.

Kawamura Kazunori K   Mori Wakana W   Fujinaga Masayuki M   Yamasaki Tomoteru T   Zhang Yiding Y   Wakizaka Hidekatsu H   Hatori Akiko A   Xie Lin L   Kumata Katsushi K   Ohkubo Takayuki T   Kurihara Yusuke Y   Ogawa Masanao M   Nengaki Nobuki N   Zhang Ming-Rong MR  

EJNMMI radiopharmacy and chemistry 20190218 1


<h4>Background</h4>Neuropeptide Y (NPY) has been implicated in a wide variety of physiological processes, including feeding, learning, memory, emotion, cardiovascular homeostasis, hormone secretion, and circadian rhythms. NPY Yl receptor (NPY Y1-R) is the most widely studied NPY receptor, and is involved in many of these processes. BMS-193885 (1) was previously developed as a potent and selective NPY Y1-R antagonist, which has good systemic bioavailability and brain penetration. To evaluate the  ...[more]

Similar Datasets

| S-EPMC3075237 | biostudies-literature
| S-EPMC5346983 | biostudies-literature
| S-EPMC5949725 | biostudies-literature
| S-EPMC3979304 | biostudies-literature
| S-EPMC5233741 | biostudies-literature
| S-EPMC1302420 | biostudies-other
| S-EPMC2792991 | biostudies-literature
| S-EPMC8508546 | biostudies-literature
| S-EPMC5559324 | biostudies-other
| S-EPMC2646255 | biostudies-literature